AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.29
+0.27 (2.69%)
At close: Jun 26, 2026, 4:00 PM EDT
10.32
+0.03 (0.29%)
After-hours: Jun 26, 2026, 7:31 PM EDT
AdaptHealth Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for AdaptHealth stock have an average target of 13.93, with a low estimate of 9.50 and a high estimate of 18. The average target predicts an increase of 35.37% from the current stock price of 10.29.
Analyst Consensus: Buy
* Price targets were last updated on May 8, 2026.
Analyst Ratings
The average analyst rating for AdaptHealth stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $13 → $15 | Buy | Maintains | $13 → $15 | +45.77% | May 8, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $17 → $18 | Buy | Maintains | $17 → $18 | +74.93% | May 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $14 → $16 | Buy | Maintains | $14 → $16 | +55.49% | May 7, 2026 |
| UBS | UBS | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +36.05% | May 7, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $14 | Buy | Reiterates | $14 | +36.05% | May 6, 2026 |
Financial Forecast
Revenue This Year
3.49B
from 3.24B
Increased by 7.48%
Revenue Next Year
3.71B
from 3.49B
Increased by 6.46%
EPS This Year
0.84
from 0.54
Increased by 54.89%
EPS Next Year
1.18
from 0.84
Increased by 39.86%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.5B | 3.8B | |
| Avg | 3.5B | 3.7B | |
| Low | 3.4B | 3.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.0% | 8.4% | |
| Avg | 7.5% | 6.5% | |
| Low | 6.3% | 3.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.11 | 1.49 | |
| Avg | 0.84 | 1.18 | |
| Low | 0.58 | 0.82 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 104.5% | 77.2% | |
| Avg | 54.9% | 39.9% | |
| Low | 7.7% | -2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.